NICE recommends polatuzumab vedotin combination for DLBCL
- PDF / 167,222 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 46 Downloads / 230 Views
1173-5503/20/0861-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
PharmacoEconomics & Outcomes News 5 Sep 2020 No. 861
1
Data Loading...